LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹32 Cr | ₹57 Cr | ₹82 Cr | ₹69 Cr | ₹19 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LAURUS LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹82 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹19 Cr |
How is Deferred Tax Assets / Liabilities of LAURUS LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | -44.13 | |
| Mar2024 | ₹57 Cr | -30.82 | |
| Mar2023 | ₹82 Cr | 19.30 | |
| Mar2022 | ₹69 Cr | 260.32 | |
| Mar2021 | ₹19 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹49,986.6 Cr | -7.4% | -16.5% | 80.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -7.4% |
-16.5% |
80.4% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses